Quick access

PDF
Share Article:
2008 Volume 1 Issue 2

Effect of luteolin on glycoproteins metabolism in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis


Abstract
We have investigated the effect of luteolin, a flavonoid on colon cancer induced in rats by a colon specific carcinogen 1, 2 dimethylhydrazine (DMH). Rats were randomized into 5 groups of 10 animals each. Rats in group 1 received 1.0 ml of 0.5% carboxymethyl cellulose (CMC) everyday via intragastric intubation and served as the untreated control. Group 2 rats received luteolin via intragastric intubation (p.o.) at a daily dose of 0.2 mg/kg body weight. The rats in groups 3 to 5 received DMH [20 mg/kg body weight] injection once a week subcutaneously for the first 15 weeks. The group 4 rats received luteolin as in group 2 starting one week before the DMH injections and continued till one week after the final exposure [DMH + luteolin (Initiation)]. Groups 5 rats received luteolin as in group 2 starting one week after the cessation of DMH injections and continued till the end of the experiment [DMH + luteolin (Post-initiation)]. 20mg/kg body weight of DMH was administered subcutaneously once a week for the first 15 weeks and then discontinued. Luteolin 0.2mg/kg body weight/everyday p.o was administered at the initiation and also at the post-initiation stages of carcinogenesis to DMH treated rats. The animals were sacrificed at the end of 30 weeks. The incidence and number of tumors in the colon were significantly higher when the rats were administered DMH, as compared to DMH + luteolin (initiation and postinitiation) groups. Decrease in sialic acid was observed in the colon, intestine and increase in sialic acid was observed in the liver of DMH treated rats as compared to control animals. Increases in glycoconjugates (Total hexoses and fucose) were observed in the DMH treated rats as compared to control animals. Oral administration of luteolin restored the levels of glycoconjugats during DMH induced colon carcinogenesis. Thus, the present study indicates that luteolin has protected the cell surface and maintained the structural integrity of the cell membranes during DMH induced colon carcinogenesis. Keywords: Colon cancer, 1, 2-dimethylhydrazine, luteolin, glycoproteins Received: 23 January 2009 / Received in revised form: 17 February 2009, Accepted: 28 February 2009, Published online: 3 March 2009

INDEXING
SCIRUS, Chemical Abstracts, EBSCOhost databases, Genamics JournalSeek, ABCD Journl Index and many other international scientific databases.

JOURNAL OF BIOCHEMICAL TECHNOLOGY
JOURNAL OF BIOCHEMICAL TECHNOLOGY
Journal of Biochemical Technology is a double-blind peer reviewed International Journal published by the Deniz Publication on behalf of the Biochemical Technology Society, a Registered Charity Organization from India

AREA OF INTEREST
AREA OF INTEREST
new advances in enzymatic and protein mechanims; applied molecular genetics and biotechnology; genomics and proteomics; metabolic; medical, environmental, food and agro biotechnology.

FOCUS AND SCOPE
FOCUS AND SCOPE
Journal of Biochemical Technology provides a publication on all aspects of biochemistry, biotechnology & bioinformatics and applications in biology and medicine. Areas of high interest cover new advances in enzymatic and protein mechanisms; applied molecular genetics and biotechnology; computational biology, genomics and proteomics; metabolic & tissue engineering; medical, environmental, Pharmacy and pharmaceutical chemistry, food and agro-biotechnology.

Publish with us


Deniz Publication
Guzelyali Mah. Sahilyolu Cad.Defne Sok. No: 7, 34903 Pendik, Istanbul
Email: [email protected]
Tell: +905344990778

Publishing steps

1.Prepare
your paper
2.Submit
and revise
3.Track
your research
4.Share
and promote
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Keywords include, Biochemical Research: Endo/exocytosis, Trafficking, Membrane Biology, Cell Migration, Cell-Matrix Organelle Biogenesis, Cytoskeleton Proteolysis, Cell Death, Cell Cycle, Cancer, Cell Growth/Death, Differentiation, Drug Targets, Gene Therapy, Models of Disease, Proteomics, Stem Cells, Bioenergetics, Mitochondria, Free Radicals, Redox Signaling, Ion Transport/Channels, Oxidative